ICPerMed Recognition 2020

ICPerMed's third 'Best Practice in Personalised Medicine' Recognition 2020 will honour, encourage, promote and disseminate outstanding best practice examples in personalised medicine.

Responsible authors (applicants from any countries) of candidate proposal published and/or developed between January 1st, 2018 and October 31st, 2019 were eligible to apply.

The deadline for proposal submission was the 23rd of January, 2020.

The selected authors will be invited to the ICPerMed Conference 2020 and will be given the opportunity to present their results during a plenary session to stakeholders interested in the area of PM. If the first author could be not present during the conference, he or she should delegate to other member of the proposal. In addition, the successful candidates will receive a non – cash support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of € 500.

Topic of the call

The applications cover at least one of three defined topics linked to “Health systems enabling personally tailored and valuable health promotion, prevention, diagnosis and treatment”. The best practice examples can consist of one or several of the following:

  1. Scientific paper focused on novel approaches for the implementation of PM
  2. Training programmes for health personnel, increasing the level of awareness on the potential of PM
  3. Examples for interdisciplinary or inter-sectoral groups of collaboration (governmental and non-governmental organizations, academic management, medical research and Health Care and Industry for the Implementation of PM, including Ethical, Legal and Social Issues (ELSI) activities).

Criteria Eligibility

  • Number of selected proposals: A maximum number of three examples will be selected. Open to applicants worldwide
  • The main contact person (e.g. coordinator) for the application has to be responsible for a best practise strategy in PM

Applicants should belong to one of the following groups:

  • Researchers professional
  • Representatives of Patient organisations
  • Representatives of health care providers and insurances
  • Health Care Professionals, like nurses and GPs
  • Medical Education Professionals
  • Employees of private sector / industry


The application consists of the following documents, bundled together into a single doc file:

  1. an application form describing in detail the best practice approach and intended dissemination approach
  2. a short bio sketch (maximum 1000 characters for each applicant)

The proposal (only documents submitted in English will be considered eligible) must be submitted electronically using the form, available on the ICPerMed website, and sent in .doc format to the following addresses:

Maria Grazia Mancini – mg.mancini-esterno@sanita.it
Maria Josefina Ruiz Alvarez – mj.ruizalvarez-esterno@sanita.it


Proposal Evaluation

Proposals will be evaluated in a one-stage process by selection of researchers experienced in the topic with the support of the secretariat in the scientific evaluation with final approval by the ICPerMed Executive Committee.

The proposals will be evaluated on the following criteria:

  1. Knowledge Production
    • Peer reviewed publications and citations
    • Other publications such as books, book chapters, editorials or bulletins
    • Presentations to national and international conferences
    • Research reports and ‘grey literature’ produced
    • Cochrane systematic reviews produced
  2. Research capacity-building and targeting
    • Education and training of personnel such as clinicians, health professionals and scientists
    • Higher degrees, such as PhD, obtained by research personnel
    • Research personnel attracted from overseas and retention of personnel
    • Spin-off projects developed and further research funding leveraged
    • Development and use of novel research techniques
    • Establishment of new datasets, databases or research data lodged in national database
    • New national/international collaborations or strategic partnerships formed with other
    • research teams, industrial partners or health agencies
    • Internationalization of research: Involvement of researchers with different European
    • origin and global health research initiatives
  3. Informing policy and practice
    • Dissemination and knowledge-transfer events or networks established with research
    • ‘users’ such as policy-makers and health professionals
    • Advisory roles of involved researchers to government and policy-makers
    • Commissioned reports from government departments or agencies
    • Policy briefing papers, practical handbooks and other grey material disseminated to
    • research users
    • Contribution of research to clinical treatment or best practice guidelines
    • Public outreach and dissemination through media and other
  4. Population health and health sector benefits
    • Contribution of respective research to health promotion initiatives
    • Randomized control trials completed and new interventions established as a result
    • Numbers of patients enrolled on clinical trials or engaged with studies undertaken in
    • clinical research facilities
    • Contribution of respective research to actual health benefits for the general public
    • Savings to the health system through gains in health service efficiency, improved
    • primary care or introduction of preventative health measures, where the respective
    • research/personnel contributed to this
    • Reduced health inequalities in health status and healthcare through where respective
    • research/personnel contributed to this
    • Increased availability of local pool of evidence and evidence “generators” to health
    • policy-makers and health practitioners on the regional, national, European and/or international level
  5. Economic impacts
    • Patents, invention disclosures and other IP applications and award of
    • commercialization support grants to develop marketable products
    • Licence agreements and revenues generated as a result
    • Spin-out companies formed and employment gained
    • Success of involved personnel in attaining international research funding, for example
    • though EU Framework Programmes
    • Success of involved research facilities and centres in attracting and maintaining PhD qualified research workforce
    • Proxy measures of enhanced international reputation of participating partners and their
    • respective countries for health research (e.g. by attracting pharma industry R&D; formal
    • collaborative partnerships developed between researchers and industry)
    • Economic GDP gains from improved patient care and population health where link to the respective research/study can be established

For each criterion, the proposal will be scored from 1 to 5 (half marks are possible).
Total Score: 1-5; THRESHOLD for average of each criteria >2

The proposal cannot be assessed due to missing or incomplete information;

  1. Poor: there are serious inherent weaknesses;
  2. Fair: the proposal broadly addresses the criterion but there are significant weaknesses;
  3. Good: the proposal addresses the criterion well but with a number of shortcomings;
  4. Very good: the proposal addresses the criterion very well but with a small number of shortcomings;
  5. Excellent: the proposal successfully addresses all relevant aspects of the criterion; any shortcomings are minor

A higher score will be given to the application that covers concretely more than one of the given
topics (two topics included : + 0,5 ; max. score allowed when three topics are covered : +1):

  1. Scientific paper focused on novel approaches for the implementation of PM
  2. Training programmes for health personnel, increasing the level of awareness on the potential of PM
  3. Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organizations, academic management, medical research and Health Care), for the implementation of PM, including Ethical, Legal and Social Issues (ELSI) activities.

Based on the evaluation, the highest ranking proposal for each topic will receive the prize. These
resumes will be published via ICPerMed website.

Evaluation process (two steps):

  1. Individual evaluation by experts.
  2. Agreement by ExCom partners.

Experts work individually. Each expert gives a score for each criterion, with explanatory comments, and prepares an ‘individual evaluation report (IER)’. They also indicate if the proposal falls entirely outside the scope of the part of the call which they are evaluating.

After carrying out an individual evaluation, an expert will join other experts who have evaluated the same proposal in a consensus group, to agree on a common position, including comments and scores.

Each group is assisted by the secretariat who seeks a consensus, impartially and ensures that each proposal is evaluated fairly, according to the evaluation criteria.  

If the number of applications is higher than 50, the secretariat organization will explore the need  of a face to face meeting  with the Panel of evaluators. The participation of two Steering Board members and/or secretariat members as observers could be considered.”

The grants will be recognized based on the ranking and the available funds for the year.

Applicants will receive notification of the funding decision, as well as the summaries of the reviewers’ comments. A list of successful applicants will be published on the ICPerMed website. There is no appeal process.

Dissemination Scheme

The objective of this recognition is to encourage and disseminate best practice examples in personalised medicine. With this vision, the winner(s) will be invited to the ICPerMed Conference 2020 and will be given the opportunity to present their results during a plenary session. In addition, the successful candidates will receive support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of € 500,00.

Recognition winners should provide publishable summary and funding information for ICPerMed website.

The aim of this dissemination is to provide the winner with an opportunity to seek supplementary dissemination activities that will accelerate and maximise the potential impact of the research findings and learnings gained on best practice on PM.

The dissemination responsibility will be centred on ICPerMed and the package of dissemination will be aligned with the current stage of the research process and with the target audience/s.


The information on the ICPerMed Recognition will be available on the webpage of ICPerMed. The ICPerMed Secretariat will be responsible for the management of the evaluation process. The applicants will be informed about the decisions individually by the ICPerMed Secretariat only after is reached the consensus by the ICPerMed ExCom.

Ceremony for Recognition Presentation:

The selected proposals will be invited as a special ICPerMed lecturer in the 2020 ICPerMed Conference in Paris (October 15-16, 2020). Travel costs related to the lecturer and the evaluators will be covered by ICPerMed.

Call Schedule

Year Date Activity Comments
2019 October 7th Preliminary-Announcement Website ICPerMed
2019 November 5th Launch of the call Website ICPerMed
2nd ICPerMed Workshop. Madrid
2020 January 23rd Deadline for presenting proposals  
2020 March 21st Deadline for Evaluation/selection  of proposals  
2020 April Selection communication Website ICPerMed & ExCom Meeting
2020 October   Recognition 2020 presentation 2nd ICPerMed Conference, Paris